Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

Author： Rocca Andrea Viale Giuseppe Gelber Richard Bottiglieri Luca Gelber Shari Pruneri Giancarlo Ghisini Raffaella Balduzzi Alessandra Pietri Elisabetta D’Alessandro Claudia Goldhirsch Aron Colleoni Marco

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.61, Iss.6, 2008-05, pp. : 965-971

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients

By Kawate Takahiko

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 51-59

Springer Publishing Company

Access to resources Recommend Favorite

Accelerated Cisplatin-based Chemotherapy for Advanced Bladder Cancer

By Boshoff C. Oliver R.T.D. Gallagher C.J. J. O.

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1633-1636

Elsevier

Access to resources Recommend Favorite

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 211-213

Informa Healthcare

Access to resources Recommend Favorite

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 145-147

Informa Healthcare

Access to resources Recommend Favorite

Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 15-21

Spandidos Publications

Access to resources Recommend Favorite